Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 215Precursor Cell Lymphoblastic Leukemia-Lymphoma 188Lymphoma, Large B-Cell, Diffuse 172Leukemia 102Burkitt Lymphoma 91Lymphoma, Non-Hodgkin 89Lymphoma, Follicular 78Lymphoma, Mantle-Cell 53Neuroblastoma 51Hodgkin Disease 46Central Nervous System Neoplasms 42Sarcoma 37Lymphoma, B-Cell 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Lymphoma, Large-Cell, Anaplastic 29Recurrence 28Lymphoma, T-Cell, Peripheral 28Lymphoma, Large-Cell, Immunoblastic 27Rhabdomyosarcoma 25Neoplasms 25Multiple Myeloma 24Medulloblastoma 22Lymphoma, B-Cell, Marginal Zone 22Leukemia, Lymphocytic, Chronic, B-Cell 21Leukemia, Biphenotypic, Acute 21Brain Neoplasms 20Sarcoma, Ewing 18Retinoblastoma 18Lymphoma, T-Cell 17HIV Infections 17

Interventions

ofatumumab 1liposomal doxorubicin 1isatuximab 1cabazitaxel 1Zidovudine 1XRP6258 1Vincristine 1Valganciclovir 1Tonsillectomy 1Surveys and Questionnaires 1Sirolimus 1Rituximab 1Ritonavir 1Quality of Life 1Prednisone 1Needles 1Metformin 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Doxorubicin 1Cyclophosphamide 1Carboplatin 1Bortezomib 1Biopsy, Fine-Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphadenopathy × Vincristine × Clear all
NCT00092222 2026-05-22

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡